The director of the National Center for Disease Control (NCDC), Badr Al-Din Al-Najjar, announced the initiation of harvesting blood plasma of patients who have achieved full recovery from the Coronavirus infection.
The plasma is intended for use in the treatment of people presently infected with COVID-19, and possibly other viral diseases.
He said that all recommendations of the Ethical and Biological Committee of the NCDC are strictly adhered to and all patients are fully informed about the procedure before making any decision on the treatment.
Health
